Trial Details
NOT_YET_RECRUITINGBasic Information
| Clinical ID | c844 |
|---|---|
| Identifier | NCT06880744 |
| Trial Title | A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Risankizumab|DRUG: Risankizumab|DRUG: Vedolizumab |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | Lancaster |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-06-26 |
|---|---|
| Primary Completion Date | 2025-09-28 |
| Completion Date | 2025-09-28 |